Pathophysiology of Signal Transduction in Cardiovascular and Pulmonary Disease II
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 1 August 2024 | Viewed by 136
Special Issue Editors
2. College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
Interests: cardiac arrhythmia; heart failure; vascular biology
Special Issues, Collections and Topics in MDPI journals
Interests: pulmonary hypertension; prostaglandin signaling; endothelial mesenchymal transition; cellular and molecular pathobiology of pulmonary hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The cardiopulmonary system includes the heart, blood vessels and blood, trachea, bronchi, and lungs. The central function of the cardiopulmonary system involves a process that centers upon the connection between the heart and lungs through the pulmonary artery, enabling the efficient movement of blood to and from the lungs, where oxygen and carbon dioxide are exchanged.
Cardiovascular disease and pulmonary disease are complicated. There are a series of molecules and complex intracellular mechanisms in the cells of the heart and blood vessel walls that cause cells to respond inappropriately to external stimulation. Cells involved in the defective regulation respond to changes in their local environment through the activation of molecules. Defects in these mechanisms can lead to cardiovascular disease and pulmonary disease. The study of signal transduction pathways in the cardiopulmonary system is important because it can provide more drug targets and methods for the treatment of cardiovascular disease and pulmonary disease by elucidating the pathophysiology of signal transduction and the coordinated responses of multiple signaling pathways.
This Special Issue focuses on multiple aspects of the signal transduction of cells in the cardiopulmonary system, especially in cardiac arrhythmia and pulmonary hypertension, and will accept original studies and reviews in the field of the pathophysiology of signal transduction in cardiovascular and pulmonary disease, written by scientists active in the field.
Dr. Yung-Hsin Yeh
Dr. Ying-Ju Lai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiac arrhythmia
- atrium
- ventricle
- pulmonary
- vascular
- signal transduction
